Jump to content

Atorolimumab

From Wikipedia, the free encyclopedia
Atorolimumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
TargetRhD
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
 ☒NcheckY (what is this?)  (verify)

Atorolimumab is an immunosuppressive drug directed against the Rhesus factor.[1][2]

References

[edit]
  1. ^ WHO Drug Information
  2. ^ Pelletier JP, Mukhtar F (2020). "Chapter 16 - Passive Monoclonal and Polyclonal Antibody Therapies". In Maitta RW (ed.). Immunologic Concepts in Transfusion Medicine. Philadelphia: Elsevier. p. 267. doi:10.1016/B978-0-323-67509-3.00016-0. ISBN 978-0-323-67510-9. S2CID 213508934.